Intel 10-Q 2025-06-28
INTC · CIK 50863 · Form 10-Q · Period ended June 28, 2025 · Filed July 24, 2025
Revenue rose 0.2% to $12.9 billion. Operating margin was -24.7%, against -15.3% a year earlier. The net loss was $2.92 billion.
8 sections, 269K characters. Original on sec.gov · ·
| Measure | Quarter ended Jun 28, 2025 | Quarter ended Jun 29, 2024 | Change |
|---|---|---|---|
| Revenue | $12.9B | $12.8B | +0.2% |
| Operating income | -$3.18B | -$1.96B | n/a |
| Net income | -$2.92B | -$1.61B | n/a |
| Diluted EPS | -$0.67 | -$0.38 | n/a |
| Cash and equivalents | $9.64B | n/a | n/a |
| Operating margin* | -24.7% | -15.3% | -9.4 pts |
From the XBRL facts tagged to this filing; both columns are as reported in this filing. * Computed by filings.tools: free cash flow is operating cash flow less capital spending; operating margin is operating income over revenue.
Cover and table of contents
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-Q
(Mark One)
| ☑ | QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 | ||||||||||
| For the quarterly period ended | June 28, 2025 |
or
| ☐ | TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 | |||||||
| For the transition period from to |
Commission File Number: 000-06217

INTEL CORPORATION
(Exact name of registrant as specified in its charter)
| Delaware | 94-1672743 | |||||||||||||
| (State or other jurisdiction of incorporation or organization) | (I.R.S. Employer Identification No.) | |||||||||||||
| 2200 Mission College Boulevard, | Santa Clara, | California | 95054-1549 | |||||||||||
| (Address of principal executive offices) | (Zip Code) |
(408) 765-8080
(Registrant’s telephone number, including area code)
N/A
(Former name, former address and former fiscal year, if changed since last report)
Securities registered pursuant to Section 12(b) of the Act:
| Title of each class | Trading symbol(s) | Name of each exchange on which registered | ||||||
| Common stock, $0.001 par value | INTC | Nasdaq Global Select Market |
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☑ No ¨
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☑ No ¨
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and "emerging growth company" in Rule 12b-2 of the Exchange Act.
| Large accelerated filer | Accelerated filer | Non-accelerated filer | Smaller reporting company | Emerging growth company | |||||||||||||||||||
| ☑ | ¨ | ¨ | ☐ | ☐ | |||||||||||||||||||
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☑
As of July 18, 2025, the registrant had outstanding 4,377 million shares of common stock.
Table of Contents
Organization of Our Form 10-Q
The order and presentation of content in our Form 10-Q differs from the traditional SEC Form 10-Q format. Our format is designed to improve readability and better present how we organize and manage our business. See "Form 10-Q Cross-Reference Index" within Risk Factors and Other Key Information for a cross-reference index to the traditional SEC Form 10-Q format.
We have defined certain terms and abbreviations used throughout our Form 10-Q in "Key Terms" within the Consolidated Condensed Financial Statements and Supplemental Details.
| Page | |||||||||||
| Forward-Looking Statements | 1 | ||||||||||
| Availability of Company Information | 2 | ||||||||||
| Consolidated Condensed Financial Statements and Supplemental Details | |||||||||||
| Consolidated Condensed Statements of Operations | 3 | ||||||||||
| Consolidated Condensed Statements of Comprehensive Income (Loss) | 4 | ||||||||||
| Consolidated Condensed Balance Sheets | 5 | ||||||||||
| Consolidated Condensed Statements of Cash Flows | 6 | ||||||||||
| Consolidated Condensed Statements of Stockholders' Equity | 7 | ||||||||||
| Notes to Consolidated Condensed Financial Statements | 8 | ||||||||||
| Key Terms | 25 | ||||||||||
| Management's Discussion and Analysis (MD&A) | |||||||||||
| Operating Segments Trends and Results | 27 | ||||||||||
| Consolidated Condensed Results of Operations | 31 | ||||||||||
| Liquidity and Capital Resources | 37 | ||||||||||
| Critical Accounting Estimates | 38 | ||||||||||
| Risk Factors and Other Key Information | |||||||||||
| Risk Factors | 41 | ||||||||||
| Quantitative and Qualitative Disclosures About Market Risk | 42 | ||||||||||
| Controls and Procedures | 42 | ||||||||||
| Issuer Purchases of Equity Securities | 43 | ||||||||||
| Rule 10b5-1 Trading Arrangements | 43 | ||||||||||
| Disclosure Pursuant to Section 13(r) of the Securities Exchange Act of 1934 | 43 | ||||||||||
| Amendment and Restatement of the 2006 Equity Incentive Plan | 43 | ||||||||||
| Exhibits | 44 | ||||||||||
| Form 10-Q Cross-Reference Index | 45 |
Forward-Looking Statements
This Form 10-Q contains forward-looking statements that involve a number of risks and uncertainties. Words such as "accelerate", "achieve", "aim", "ambitions", "anticipate", "believe", "committed", "continue", "could", "designed", "estimate", "expect", "forecast", "future", "goals", "grow", "guidance", "intend", "likely", "may", "might", "milestones", "next generation", "objective", "on track", "opportunity", "outlook", "pending", "plan", "position", "possible", "potential", "predict", "progress", "ramp", "roadmap", "seek", "should", "strive", "targets", "to be", "upcoming", "will", "would", and variations of such words and similar expressions are intended to identify such forward-looking statements, which may include statements regarding:
**▪**our business plans and strategy and anticipated benefits therefrom, including with respect to our intentions and expectations for Intel 14A, our IDM strategy, our Smart Capital strategy, our partnerships with Apollo and Brookfield, our internal foundry model, our updated reporting structure, and our AI strategy;
**▪**projections of our future financial performance, including future revenue, gross profits, capital expenditures, and cash flows;
**▪**projected costs and yield trends;
**▪**future cash requirements, the availability, uses, sufficiency, and cost of capital resources, and sources of funding, including for future capital and R&D investments and for returns to stockholders, such as stock repurchases and dividends, and credit ratings expectations;
**▪**future products, services, and technologies, and the expected goals, timeline, ramps, progress, availability, production, regulation, and benefits of such products, services, and technologies, including future process nodes and packaging technology, product roadmaps, schedules, future product architectures, expectations regarding process performance, per-watt parity, and metrics, and expectations regarding product and process leadership;
**▪**investment plans and impacts of investment plans, including in the US and abroad;
**▪**internal and external manufacturing plans, including future internal manufacturing volumes, manufacturing expansion plans and the financing therefor, and external foundry usage;
**▪**future production capacity and product supply;
**▪**supply expectations, including regarding constraints, limitations, pricing, and industry shortages;
**▪**plans and goals related to Intel's foundry business, including with respect to anticipated customers, future manufacturing capacity and service, technology, and IP offerings;
**▪**expected timing and impact of acquisitions, divestitures, and other significant transactions, including the agreed-upon sale of a controlling interest of Altera;
**▪**expected completion and impacts of restructuring activities and cost-saving or efficiency initiatives;
**▪**future social and environmental performance goals, measures, strategies, and results;
**▪**our anticipated growth, future market share, customer demand, and trends in our businesses and operations;
**▪**projected growth and trends in markets relevant to our businesses;
**▪**anticipated trends and impacts related to industry component, substrate, and foundry capacity utilization, shortages, and constraints;
**▪**expectations regarding government incentives, policies, and priorities;
**▪**future technology trends and developments, such as AI;
**▪**future macro environmental and economic conditions;
**▪**geopolitical tensions and conflicts, including with respect to international trade policies in areas such as tariffs and export controls, and their potential impact on our business;
**▪**tax- and accounting-related expectations;
**▪**expectations regarding our relationships with certain sanctioned parties; and
**▪**other characterizations of future events or circumstances.
Such statements involve many risks and uncertainties that could cause our actual results to differ materially from those expressed or implied, including those associated with:
**▪**the high level of competition and rapid technological change in our industry;
**▪**the significant long-term and inherently risky investments we are making in R&D and manufacturing facilities that may not realize a favorable return;
**▪**the complexities and uncertainties in developing and implementing new semiconductor products and manufacturing process technologies;
**▪**our ability to time and scale our capital investments appropriately and successfully secure favorable alternative financing arrangements and government grants;
▪a potential pause or discontinuation of our pursuit of Intel 14A and other next generation leading-edge process technologies if we are unable to secure a significant external customer for Intel 14A;
▪implementing new business strategies and investing in new businesses and technologies;
**▪**changes in demand for our products;
| 1 |
**▪**macroeconomic conditions and geopolitical tensions and conflicts, including geopolitical and trade tensions between the US and China, the impacts of Russia's war on Ukraine, tensions and conflict affecting Israel and the Middle East, and rising tensions between mainland China and Taiwan;
**▪**the evolving market for products with AI capabilities;
**▪**our complex global supply chain supporting our manufacturing facilities and incorporating external foundries, including from disruptions, delays, trade tensions and conflicts, or shortages;
**▪**recently elevated geopolitical tensions, volatility and uncertainty with respect to international trade policies, including tariffs and export controls, impacting our business, the markets in which we compete and the world economy;
**▪**product defects, errata and other product issues, particularly as we develop next-generation products and implement next-generation manufacturing process technologies;
**▪**potential security vulnerabilities in our products;
**▪**increasing and evolving cybersecurity threats and privacy risks;
**▪**IP risks including related litigation and regulatory proceedings;
**▪**the need to attract, retain, and motivate key talent;
**▪**strategic transactions and investments;
**▪**sales-related risks, including customer concentration and the use of distributors and other third parties;
**▪**our significantly reduced return of capital in recent years;
**▪**our debt obligations and our ability to access sources of capital;
**▪**complex and evolving laws and regulations across many jurisdictions;
**▪**fluctuations in currency exchange rates;
**▪**changes in our effective tax rate and applicable tax regimes;
**▪**catastrophic events;
**▪**environmental, health, safety, and product regulations;
**▪**our initiatives and new legal requirements with respect to corporate responsibility matters; and
**▪**other risks and uncertainties described in this report, our 2024 Form 10-K and our other filings with the SEC.
Given these risks and uncertainties, readers are cautioned not to place undue reliance on such forward-looking statements. Readers are urged to carefully review and consider the various disclosures made in this Form 10-Q and in other documents we file from time to time with the SEC that disclose risks and uncertainties that may affect our business.
Unless specifically indicated otherwise, the forward-looking statements in this Form 10-Q do not reflect the potential impact of any divestitures, mergers, acquisitions, or other business combinations that have not been completed as of the date of this filing. In addition, the forward-looking statements in this Form 10-Q are based on management's expectations as of the date of this filing, unless an earlier date is specified, including expectations based on third-party information and projections that management believes to be reputable. We do not undertake, and expressly disclaim any duty, to update such statements, whether as a result of new information, new developments, or otherwise, except to the extent that disclosure may be required by law.
Availability of Company Information
We use our Investor Relations website, www.intc.com*,* as a routine channel for distribution of important, and often material, information about us, including our quarterly and annual earnings results and presentations, press releases, announcements, information about upcoming webcasts, analyst presentations, and investor days, archives of these events, financial information, corporate governance practices, and corporate responsibility information. We also post our filings on this website the same day they are electronically filed with, or furnished to, the SEC, including our annual and quarterly reports on Forms 10-K and 10-Q and current reports on Form 8-K, our proxy statements, and any amendments to those reports. All such information is available free of charge. Our Investor Relations website allows interested persons to sign up to automatically receive e-mail alerts when we post financial information and issue press releases, and to receive information about upcoming events. We encourage interested persons to follow our Investor Relations website in addition to our filings with the SEC to timely receive information about the company.
Intel, the Intel logo, Intel Core, Gaudi, and Altera are trademarks of Intel Corporation or its subsidiaries in the US and/or other countries.
** Other names and brands may be claimed as the property of others.*
| 2 |
Item 1. Financial Statements
| Consolidated Condensed Statements of Operations | |||||
| Three Months Ended | Six Months Ended | |||||||||||||||||||||||||
| (In Millions, Except Per Share Amounts; Unaudited) | Jun 28, 2025 | Jun 29, 2024 | Jun 28, 2025 | Jun 29, 2024 | ||||||||||||||||||||||
| Net revenue | $ | 12,859 | $ | 12,833 | $ | 25,526 | $ | 25,557 | ||||||||||||||||||
| Cost of sales | 9,317 | 8,286 | 17,312 | 15,793 | ||||||||||||||||||||||
| Gross profit | 3,542 | 4,547 | 8,214 | 9,764 | ||||||||||||||||||||||
| Research and development | 3,684 | 4,239 | 7,324 | 8,621 | ||||||||||||||||||||||
| Marketing, general, and administrative | 1,144 | 1,329 | 2,321 | 2,885 | ||||||||||||||||||||||
| Restructuring and other charges | 1,890 | 943 | 2,046 | 1,291 | ||||||||||||||||||||||
| Operating expenses | 6,718 | 6,511 | 11,691 | 12,797 | ||||||||||||||||||||||
| Operating income (loss) | (3,176) | (1,964) | (3,477) | (3,033) | ||||||||||||||||||||||
| Gains (losses) on equity investments, net | 502 | (120) | 390 | 85 | ||||||||||||||||||||||
| Interest and other, net | (95) | 80 | (268) | 225 | ||||||||||||||||||||||
| Income (loss) before taxes | (2,769) | (2,004) | (3,355) | (2,723) | ||||||||||||||||||||||
| Provision for (benefit from) taxes | 255 | (350) | 556 | (632) | ||||||||||||||||||||||
| Net income (loss) | (3,024) | (1,654) | (3,911) | (2,091) | ||||||||||||||||||||||
| Less: net income (loss) attributable to non-controlling interests | (106) | (44) | (172) | (100) | ||||||||||||||||||||||
| Net income (loss) attributable to Intel | $ | (2,918) | $ | (1,610) | $ | (3,739) | $ | (1,991) | ||||||||||||||||||
| Earnings (loss) per share attributable to Intel—basic | $ | (0.67) | $ | (0.38) | $ | (0.86) | $ | (0.47) | ||||||||||||||||||
| Earnings (loss) per share attributable to Intel—diluted | $ | (0.67) | $ | (0.38) | $ | (0.86) | $ | (0.47) | ||||||||||||||||||
| Weighted average shares of common stock outstanding: | ||||||||||||||||||||||||||
| Basic | 4,369 | 4,267 | 4,356 | 4,254 | ||||||||||||||||||||||
| Diluted | 4,369 | 4,267 | 4,356 | 4,254 |
See accompanying notes.
![]() | Financial Statements | Consolidated Condensed Statements of Income | 3 |
| Consolidated Condensed Statements of Comprehensive Income (Loss) | |||||
| Three Months Ended | Six Months Ended | |||||||||||||||||||||||||
| (In Millions; Unaudited) | Jun 28, 2025 | Jun 29, 2024 | Jun 28, 2025 | Jun 29, 2024 | ||||||||||||||||||||||
| Net income (loss) | $ | (3,024) | $ | (1,654) | $ | (3,911) | $ | (2,091) | ||||||||||||||||||
| Changes in other comprehensive income (loss), net of tax: | ||||||||||||||||||||||||||
| Net unrealized holding gains (losses) on derivatives | 550 | (153) | 775 | (481) | ||||||||||||||||||||||
| Actuarial valuation and other pension benefits (expenses), net | — | — | 1 | — | ||||||||||||||||||||||
| Translation adjustments and other | 1 | (1) | — | — | ||||||||||||||||||||||
| Other comprehensive income (loss) | 551 | (154) | 776 | (481) | ||||||||||||||||||||||
| Total comprehensive income (loss) | (2,473) | (1,808) | (3,135) | (2,572) | ||||||||||||||||||||||
| Less: comprehensive income (loss) attributable to non-controlling interests | (106) | (44) | (172) | (100) | ||||||||||||||||||||||
| Total comprehensive income (loss) attributable to Intel | $ | (2,367) | $ | (1,764) | $ | (2,963) | $ | (2,472) | ||||||||||||||||||
See accompanying notes.
![]() | Financial Statements | Consolidated Condensed Statements of Comprehensive Income | 4 |
| Consolidated Condensed Balance Sheets | |||||
| (In Millions; Unaudited) | Jun 28, 2025 | Dec 28, 2024 | ||||||||||||
| Assets | ||||||||||||||
| Current assets: | ||||||||||||||
| Cash and cash equivalents | $ | 9,643 | $ | 8,249 | ||||||||||
| Short-term investments | 11,563 | 13,813 | ||||||||||||
| Accounts receivable, net | 2,360 | 3,478 | ||||||||||||
| Inventories | 11,377 |
Showing the first 8K of 144K characters. Open the full section
Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations
| Management's Discussion and Analysis | |||||
This report should be read in conjunction with our 2024 Form 10-K where we include additional information on our business, operating segments, risk factors, critical accounting estimates, policies, and the methods and assumptions used in our estimates, among other important information. The Critical Accounting Estimates discussed in this Form 10-Q supplement the significant accounting policies outlined in "Note 2: Accounting Policies" within Notes to Consolidated Financial Statements within our Annual Report on Form 10-K for the fiscal year ended December 28, 2024.
In Q2 2025, we initiated an enterprise-wide initiative to fundamentally transform our culture and the way in which we operate, which is designed to simplify the way we do business and drive transparency and accountability across the company. As part of this transformation, we implemented the 2025 Restructuring Plan to lower expenses, streamline our organizational structure and reduce management layers across functions while reallocating resources toward our core client and server businesses by reducing investment in lower-priority programs and initiatives. We expect these headcount reduction initiatives will reduce our core Intel workforce by 15% by the end of fiscal 2025. As a result of initiating and deploying the 2025 Restructuring Plan, and substantially completing the 2024 Restructuring Plan, we recognized restructuring charges of $1.9 billion in Q2 2025, primarily comprised of the following:
**▪**cash-based employee severance and related employee exit charges of $1.5 billion; and
**▪**non-cash asset impairment charges of $416 million resulting from the exit of certain non-core lines of business and the consolidation and exit of certain real estate properties.
Our Q2 2025 results of operations were also affected by an impairment charge and accelerated depreciation related to certain manufacturing assets that were determined to have no remaining operational use. This determination was based on an evaluation of our current process technology node capacities relative to projected market demand for our products and services. These non-cash charges of $797 million, net of certain items, were recorded to cost of sales in Q2 2025, impacting the results for our Intel Foundry segment.
As part of the transformation of the company, we have begun implementing a more disciplined approach to the deployment of capital. The design, development, and manufacturing of leading-edge semiconductor manufacturing process technologies, or nodes, is risky and capital-intensive, and it takes years for capital investments to yield a return. Under our more disciplined approach, we intend to invest capital in future node development and additional or upgraded manufacturing facilities only where we have a clear line of sight to an acceptable return on that capital. We expect to release the first SKU of our first products manufactured on our new leading-edge node, Intel 18A, by the end of 2025, and continue to develop its derivative node, Intel 18A-P, designed for future Intel products and external customers. We are focused on the continued development of Intel 14A, the next generation node beyond Intel 18A and Intel 18A-P, and on securing a significant external customer for such node. However, if we are unable to secure a significant external customer and meet important customer milestones for Intel 14A, we face the prospect that it will not be economical to develop and manufacture Intel 14A and successor leading-edge nodes on a go-forward basis. In such event, we may pause or discontinue our pursuit of Intel 14A and successor nodes and various of our manufacturing expansion projects. While we continue to evaluate Intel 14A for use in future Intel products and our plan includes an initial product designed to utilize Intel 14A, at present we are maintaining the option to design future Intel products requiring nodes with performance beyond Intel 18A and Intel 18A-P to be produced internally or by an external foundry. If we were to discontinue development of Intel 14A and successor nodes, we expect that a majority of our products would continue to be manufactured in our own facilities utilizing our nodes up to Intel 18A-P through at least 2030. By focusing on our customers and delivering the best semiconductor products to the market, manufactured on the most appropriate internal or external node from a performance and cost perspective, and only deploying capital on new nodes and manufacturing facilities where we believe they will yield an attractive return, we believe we can improve the competitiveness of our products business, and the overall financial results for the company.
Separately, in recent months, hostilities in Israel and the surrounding region escalated significantly with direct military actions between Israel and Iran and military strikes by the United States against Iran. There can be no assurance that any existing or future ceasefire agreements will be respected or remain in force, and additional hostilities and escalations remain possible at any time. We continue to monitor the impact this geopolitical conflict could have on our operations in Israel, including potential disruption of our wafer fabrication facility and our product development centers. To date, we have not had a material interruption in either our manufacturing operations or our product development centers. As a significant portion of our revenues are generated from products on Intel 7 manufactured at our fabrication facility in Israel and we are not insured for business interruptions resulting from war or political violence, a disruption of that facility could have a significant adverse impact on our business. Additionally, our property, plant, and equipment assets in Israel are self-insured for losses resulting from war or political violence and could be impacted by the conflict.
In Q1 2025, we made an organizational change to integrate NEX into CCG and DCAI and modified our segment reporting to align to this and certain other business reorganizations. All prior period segment data has been retrospectively adjusted to reflect the way our CODM internally receives information and manages and monitors our operating segment performance. There were no changes to our consolidated financial statements for any prior periods. Our discussion regarding our segments' results of operations presented below excludes the $1.9 billion of restructuring and other charges in Q2 2025 and similar charges for the other periods presented, as our CODM receives, views and uses information for decision making purposes based upon segment results that exclude such items. "Note 2: Operating Segments" within Notes to Consolidated Condensed Financial Statements of this Form 10-Q provides additional information about our operating segments, including the nature of segment revenues and expenses, and reconciles our segment revenues presented below to our total consolidated net revenues and our segment operating income (loss) presented below to our total consolidated operating income (loss) for each of the periods presented.
![]() | MD&A | 26 |
| Operating Segments Trends and Results | |||||
Intel Products
Intel Products consists substantially of the design, development, marketing, sale, support, and servicing of CPUs and related solutions for third-party customers. The manufactur
Showing the first 8K of 78K characters. Open the full section
Item 1A. Risk Factors
Risk Factors
The risks described in "Risk Factors" within Risk Factors and Other Key Information in our 2024 Form 10-K and in our Q1 2025 Form 10-Q could materially and adversely affect our business, financial condition, and results of operations, and the trading price of our common stock could decline. These risk factors do not identify all risks that we face—our operations could also be affected by factors that are not presently known to us or that we currently consider to be immaterial to our operations. Due to risks and uncertainties, known and unknown, our past financial results may not be a reliable indicator of future performance and historical trends should not be used to anticipate results or trends in future periods. In addition to the other information set forth in this Form 10-Q, including in the Forward-Looking Statements, MD&A, and the Consolidated Condensed Financial Statements and Supplemental Details sections, we have provided an additional risk factor below regarding uncertainties surrounding our pursuit of next generation leading-edge process technologies and the impact they could have on our financial results.
If we are unable to secure a significant external foundry customer for Intel 14A, our next generation semiconductor manufacturing process technology, we may pause or discontinue our pursuit of next generation leading-edge process technologies, which may have significant strategic business, financial, operational and reputational risks and repercussions.
As an integrated design manufacturer (IDM) with a products business that depends on access to leading-edge semiconductor manufacturing process technologies, or nodes, to produce competitive products, we have historically invested significant capital resources to continually develop new generations of leading-edge nodes and foundry capacity to produce such nodes. However, the design, development, and manufacturing of leading-edge nodes is risky and capital-intensive, and it takes years for capital investments to yield a return. If we are unable to secure a significant external customer for our Intel 14A node, we may pause or discontinue development of Intel 14A and subsequent next generation leading-edge nodes. While we remain focused on continued development of Intel 14A and securing such a significant external customer, we have taken steps to reduce our overall investment and have further slowed down the construction of the new leading-edge fabrication facilities we are building in Ohio. In addition, while we continue to evaluate Intel 14A for use in future Intel products and our plan includes an initial product designed to utilize Intel 14A, at present we are maintaining the option to design future Intel products requiring nodes with performance beyond Intel 18A and Intel 18A-P to be produced internally or by an external foundry. We have been unsuccessful to date in securing any significant external foundry customers for any of our nodes and our prospects for securing a significant external foundry customer for Intel 14A are uncertain.
If we were to pause or discontinue the design, development, and manufacturing of Intel 14A and other next generation leading-edge nodes, we would be subject to a number of significant strategic business, financial, operational and reputational risks and repercussions including, but not limited to:
▪Dependence on Third-Party Foundries: Our products business would, over time, become dependent on third-party foundries, particularly TSMC, as we develop products for nodes beyond Intel 18A and Intel 18A-P. We have no long-term contract with TSMC, and if we are unable to secure and maintain sufficient capacity on favorable pricing terms, we may be unable to manufacture our products in sufficient volume and at a cost that supports the continued success of our products business. Further, most of our competitors have longer and more established relationships with TSMC and other third-party foundries than we do, which may put us at a competitive disadvantage. There are few foundries capable of producing the leading-edge and near-leading-edge nodes needed for our products – currently only TSMC and Samsung. To the extent our competitors are more successful than us in securing capacity with those foundries than we are, our product roadmap, market position, and customer relationships would be materially adversely impacted.
▪Losses with respect to our Investments in R&D and Manufacturing Facilities and Equipment: We had over $100 billion of property, plant, and equipment, net on our balance sheet as of June 28, 2025, the substantial majority of which we estimate relate to our foundry business. While the significant majority of this relates to our existing and in-development nodes, including Intel 18A and Intel 18A-P, with each transition to a new node we continue to utilize some R&D and manufacturing assets from prior nodes. If we were to pause or discontinue the design, development, and manufacturing of Intel 14A and other next generation leading-edge nodes, we would expect to incur significant material impairments with respect to foundry assets that may impact our results of operations. For example, we would likely discontinue the new leading-edge fabrication facilities we are building in Ohio. We also would expect to incur additional costs and expenses as we wind down other projects and facilities and reduce headcount.
▪Loss of Eligibility for Government Incentives: In November 2024, we signed a Direct Funding Agreement with the US Department of Commerce for the award of $7.9 billion in government incentives. We have also entered into other government incentive arrangements with local, regional, and national governments, both US and non-US. If we were to pause or discontinue the design, development, and manufacturing of Intel 14A, we may lose eligibility for various incentives contemplated by these arrangements, and we may be required to repay amounts already received under these arrangements.
▪Potential Penalty Payments Under our SCIP Agreements: To support our capital investments in recent years, we pursued alternative financing arrangements including our 2022 joint investment with Brookfield in the manufacturing expansion of our Arizona campus and our 2024 joint investment with Apollo related to Fab 34 in Ireland. Our potential pause or discontinuation of the design, development, and manufacture of Intel 14A may accelerate our move to third-party foundry services for our products and result in our inability to satisfy construction and/or wafer demand and purchase commitments in those arrangements, potentially requiring substantial additional payments to our SCIP partners.
![]() | Other Key Information | 41 |
▪Loss of Talent: Historically, as one of the only companies in the world, and the only company in the U.S., pursuing the design, development and manufacturing of next generation leading-edge nodes, we have benefitted from being in a unique position as an employer to hire and retain scientists, engineers, and other technical talent interested in being on the cutting edge of semiconductor innovation. If we were to pause or discontinue leading-edge node design, development, and manufacturing, or any perception that we may do so in the future, may materially adversely impact our ability to hire and retain key talent across our foundry organization and the company more broadly, and we risk substantial loss of historical, technical, and other expertise.
▪Limited External Foundry Potential: We have been unsuccessful to date in attracting significant customers to our external foundry business. If we were to pause or discontinue our pursuit of Intel 14A and successor nodes, it is highly uncertain whether we would be able to develop this business. Among other things, our existing nodes (Intel 7, Intel 4 and Intel 3) were designed for Intel products, and if potential customers for our upcoming Intel 18A-P node believe we are no longer committed to continued development of next generation leading-edge nodes (Intel 14A and beyond), they may be inclined to remain with their current foundry partners and unwilling to make the significant investments of time and resources needed to develop products on our nodes.
▪Other Significant Financial, Operational, and Reputational Risks: If we pause or discontinue the design, development and manufacture of Intel 14A and future leading-edge nodes, it may give rise to additional material risks that we are not able to foresee or that are more significant than we anticipate, including, but not limited to, adverse impacts to our relationships and the terms of our engagements with customers, suppliers, and strategic partners, potential credit rating risk, and diminished investor confidence and increased stock price volatility. It is also uncertain what actions, if any, may be taken by the U.S. and other governments to the extent they view a potential discontinuation of our leading-edge process technology design, development, and manufacturing as a strategic risk from a national economic or defense perspective.
Any of the foregoing could have a material adverse impact on our revenue, operations, financial position, cash flows, access to financing, cost structure, competitiveness, reputation, profitability, and prospects and could exacerbate other risks discussed in our 2024 Form 10-K and Q1 2025 Form 10-Q. Further, given the decades of significant continuous investments in R&D, talent accumulation, intellectual property, state-of-the-art facilities, and technical know-how needed to compete in leading-edge node design, development and manufacturing, any decision to pause or discontinue our pursuit of Intel 14A and successor leading-edge process technologies may be effectively irreversible.
Item 3. Quantitative and Qualitative Disclosures About Market Risk
Quantitative and Qualitative Disclosures About Market Risk
We are affected by changes in currency exchange and interest rates, as well as equity and commodity prices. Our risk management programs are designed to reduce, but may not entirely eliminate, the impacts of these risks. We performed an evaluation of these risks to our financial positions as of December 28, 2024, and updated that analysis as of June 28, 2025, to determine whether material changes in market risks pertaining to currency and interest rates or equity and commodity prices have occurred as a result of the changes in international trade policies, including tariffs and export controls. No material revisions were noted since disclosing "Quantitative and Qualitative Disclosures About Market Risk" within MD&A, in our 2024 Form 10-K. Risks related to changes in international trade policies, including tariffs and export controls, particularly those involving the United States and China are described under "Risk Factors" within Risk Factors and Other Key Information in our 2024 Form 10-K and in our Q1 2025 Form 10-Q.
Item 4. Controls and Procedures
Controls and Procedures
Inherent Limitations on Effectiveness of Controls
Our management, including the principal executive officer and principal financial officer, does not expect that our disclosure controls and procedures or our internal control over financial reporting will prevent or detect all errors and all fraud. A control system, no matter how well-designed and operated, can provide only reasonable, not absolute, assurance that the control system’s objectives will be met. The design of a control system must reflect the fact that there are resource constraints, and the benefits of controls must be considered relative to their costs. Further, because of the inherent limitations in all control systems, no evaluation of controls can provide absolute assurance that misstatements due to error or fraud will not occur or that all control issues and instances of fraud, if any, have been detected.
Evaluation of Disclosure Controls and Procedures
Based on management’s evaluation (with the participation of our principal executive officer and principal financial officer), as of the end of the period covered by this report, our principal executive officer and principal financial officer have concluded that our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended (the Exchange Act)), were effective to provide reasonable assurance that information required to be disclosed by us in reports that we file or submit under the Exchange Act is recorded, processed, summarized, and reported within the time periods specified in SEC rules and forms, and is accumulated and communicated to management, including our principal executive officer and principal financial officer, as appropriate, to allow timely decisions regarding required disclosure.
Changes in Internal Control Over Financial Reporting
There were no changes to our internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) that occurred during the quarter ended June 28, 2025 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.
![]() | Other Key Information | 42 |
Issuer Purchases of Equity Securities
We have an ongoing authorization, originally approved by our Board of Directors in 2005 and subsequently amended, to repurchase shares of our common stock in open market or negotiated transactions. No shares were repurchased during the quarter ending June 28, 2025. As of June 28, 2025, we were authorized to repurchase up to $110.0 billion, of which $7.2 billion remained available.
We issue RSUs as part of our equity incentive plans. In our Consolidated Condensed Financial Statements, we treat shares of common stock withheld for tax purposes on behalf of our employees in connection with the vesting of RSUs as common stock repurchases because they reduce the number of shares that would have been issued upon vesting. These withheld shares of common stock are not considered common stock repurchases under our authorized common stock repurchase program.
Item 5. Other Information
Rule 10b5-1 Trading Arrangements
Our directors and officers (as defined in Rule 16a-1 under the Exchange Act) may from time to time enter into plans or other arrangements for the purchase or sale of our shares that are intended to satisfy the affirmative defense conditions of Rule 10b5–1(c) or may represent a non-Rule 10b5-1 trading arrangement under the Exchange Act. During the quarter ended June 28, 2025, no such plans or arrangements were adopted or terminated, including by modification.
Disclosure Pursuant to Section 13(r) of the Securities Exchange Act of 1934
Section 13(r) of the Exchange Act requires an issuer to disclose certain information in its periodic reports if it or any of its affiliates knowingly engaged in certain activities, transactions, or dealings with individuals or entities subject to specific US economic sanctions during the reporting period, even when the activities, transactions, or dealings are conducted in compliance with applicable law. On March 2, 2021, the US Secretary of State designated the Federal Security Service of the Russian Federation (FSB) as a party subject to one such sanction. Though Intel has suspended sales in Russia, there may be a need to file documents or engage with FSB as Intel winds up our local Russian offices. All such dealings are explicitly authorized by General License 1B issued by the US Department of the Treasury’s Office of Foreign Assets Control (OFAC), and there are no gross revenues or net profits directly associated with any such dealings by us with the FSB.
On April 15, 2021, the US Department of the Treasury designated Pozitiv Teknolodzhiz, AO (Positive Technologies), a Russian IT security firm, as a party subject to one of the sanctions specified in Section 13(r). Prior to the designation, we communicated with Positive Technologies regarding its IT security research and coordinated disclosure of security vulnerabilities identified by the firm. Based on a license issued by OFAC, we resumed such communications. There are no gross revenues or net profits directly associated with any such activities. We plan to continue these communications in accordance with the terms and conditions of the OFAC license.
Amendment and Restatement of 2006 Equity Incentive Plan
As previously disclosed in our Form 8-K dated May 9, 2025, the Company's stockholders approved an amendment and restatement of the Company's 2006 Equity Incentive Plan (the “EIP”) at the 2025 Annual Stockholders’ Meeting held on May 6, 2025 (the “Annual Meeting”). The amended and restated EIP became effective upon stockholder approval and, among other changes, extended the term of the plan for an additional one year and increased by 150 million the number of shares available under the EIP, as described under Proposal 4 of the Company's definitive proxy statement filed on Schedule 14A with the Securities and Exchange Commission on March 27, 2025.
![]() | Other Key Information | 43 |
Item 6. Exhibits
Exhibits
† Management contracts or compensation plans or arrangements in which directors or executive officers are eligible to participate.
![]() | Other Key Information | 44 |
Form 10-Q Cross-Reference Index
| Item Number | Item | |||||||
| Part I - Financial Information | ||||||||
| Item 1. | Financial Statements | Pages 3 - 24 | ||||||
| Item 2. | Management's Discussion and Analysis of Financial Condition and Results of Operations | |||||||
| Liquidity and capital resources | Pages 37 - 40 | |||||||
| Results of operations | Pages 26 - 36 | |||||||
| Critical accounting estimates | Page 26, 38 | |||||||
| Item 3. | Quantitative and Qualitative Disclosures About Market Risk | Page 42 | ||||||
| Item 4. | Controls and Procedures | Page 42 | ||||||
| Part II - Other Information | ||||||||
| Item 1. | Legal Proceedings | Pages 21 - 24 | ||||||
| Item 1A. | Risk Factors | Page 41 | ||||||
| Item 2. | Unregistered Sales of Equity Securities and Use of Proceeds | Page 43 | ||||||
| Item 3. | Defaults Upon Senior Securities | Not applicable | ||||||
| Item 4. | Mine Safety Disclosures | Not applicable | ||||||
| Item 5. | Other Information | |||||||
| Rule 10b5-1 Trading Arrangements | Page 43 | |||||||
| Disclosure Pursuant to Section 13(r) of the Securities Exchange Act of 1934 | Page 43 | |||||||
| Amendment and Restatement of 2006 Equity Incentive Plan | Page 43 | |||||||
| Item 6. | Exhibits | Page 44 | ||||||
| Signatures | Page 46 |
![]() | Other Key Information | 45 |
Signatures
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
| INTEL CORPORATION (Registrant) | |||||||||||||||||
| Date: | July 24, 2025 | By: | /s/ DAVID ZINSNER | ||||||||||||||
| David Zinsner | |||||||||||||||||
| Executive Vice President, Chief Financial Officer, and Principal Financial Officer | |||||||||||||||||
| Date: | July 24, 2025 | By: | /s/ SCOTT GAWEL | ||||||||||||||
| Scott Gawel | |||||||||||||||||
| Corporate Vice President, Chief Accounting Officer, and Principal Accounting Officer |
![]() | 46 |
